Oorsprong van het eerstegraads netwerk van Susan Birdsey
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Susan Birdsey via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Investor Relations Contact | |
FORMA THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member President | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Public Communications Contact | |
Novo Nordisk Pharma NV
Novo Nordisk Pharma NV Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Novo Nordisk Pharma NV develops pharmaceuticals and treatments for people with chronic illness. The company is based in Brussels, Belgium. The CEOs are Mads Lausten, Axel de Muyt. The Belgian company was founded in 1974. | Pharmaceuticals: Major | Director/Board Member | |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Novo Nordisk Region Europe A/S
Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Director/Board Member | |
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 4 |
België | 2 |
Verenigd Koninkrijk | 2 |
Denemarken | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 6 |
Health Services | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 9 |
Public Communications Contact | 2 |
Investor Relations Contact | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Sterkste connecties
Insiders | |
---|---|
Thomas Haagen | 6 |
Amy Trevvett | 3 |
Ulrich Christian Otte | 2 |
Jamie Haney | 1 |
- Beurs
- Insiders
- Susan Birdsey
- Bedrijfsconnecties